Effect of lipoarabinomannan from Mycobacterium avium subsp avium in Freund's incomplete adjuvant on the immune response of cattle

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 2, 2012, Pages 139-146

  Colavecchia, S B ^a   Jolly, A ^a   Fernandez B ^a   Fontanals, A M ^a   Fernandez E ^a   Mundo, S L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cattle; Immunomodulation; Lipoarabinomannan; Mycobacterium avium subsp avium

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G; LIPOARABINOMANNAN; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MYCOBACTERIUM AVIUM; NONHUMAN; PARATUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SERODIAGNOSIS; TUBERCULOSIS;

BOS; MYCOBACTERIUM AVIUM;

EID: 84857663527     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500012     Document Type: Article

References (40)

1. Cox JC, Coulter AR. Adjuvants - a classification and review of their modes of action. Vaccine 1997; 15: 248-256.
2. Stills HF Jr. Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 2005; 46: 280-293.
3. Heriazon A, Thompson KA, Wilkie BN, Mathes-Sears W, Quinton M, Mallard BA. Antibody to ovalbumin and delayedtype hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freund's complete adjuvant. Vet Immunol Immunopathol 2009; 127: 220-227.
4. Hernández A, Yager JA, Wilkie BN, Leslie KE, Mallard BA. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants. Vet Immunol Immunopathol 2005; 104: 45-58.
5. Wedlock DN, Denis M, Painter GF, Ainge GD, Vordermeier HM, Hewinson RG, et al. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clin Vaccine Immunol 2008; 15: 765-772.
6. Aucouturier J, Dupuis L, Deville S, Ascarateil S, Ganne V. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines 2002; 1: 111-118.
7. Miller LH, Saul A, Mahanty S. Revisiting Freund's incomplete adjuvant for vaccines in the developing world. Trends Parasitol 2005; 21: 412-414.
8. Cobo ER, Morsella C, Cano D, Cipolla A, Campero CM. Immunization in heifers with dual vaccines containing Tritrichomonas foetus and Campylobacter fetus antigens using systemic and mucosal routes. Theriogenology 2004; 62: 1367-1382.
9. Jensen FC, Savary JR, Diveley JP, Chang JC. Adjuvant activity of incomplete Freund's adjuvant. Adv Drug Deliv Rev 1998; 32: 173-186.
10. Hunter SW, Brennan PJ. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol Chem 1990; 265: 9272-9279.
11. Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 2003; 85: 153-166.
12. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004; 53: 391-403.
13. Guerardel Y, Maes E, Elass E, Leroy Y, Timmerman P, Besra GS, et al. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1,3-mannopyranose side chains. J Biol Chem 2002; 277: 30635-30648.
14. Bhattacharjee S, Majumder N, Bhattacharyya P, Bhattacharyya S, Majumdar S. Immunomodulatory role of arabinosylated lipoarabinomannan on Leishmania donovani infected murine macrophages. Indian J Biochem Biophys 2007; 44: 366-372.
15. Barrow WW, de Sousa JP, Davis TL, Wright EL, Bachelet M, Rastogi N. Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium. Infect Immun 1993; 61: 5286-5293.
16. Smit JJ, Van Loveren H, Hoekstra MO, Schijf MA, Folkerts G, Nijkamp FP. Mycobacterium vaccae administration during allergen sensitization or challenge suppresses asthmatic features. Clin Exp Allergy 2003; 33: 1083-1089.
17. Sayers I, Severn W, Scanga CB, Hudson J, Le Gros G, Harper JL. Suppression of allergic airway disease using mycobacterial lipoglycans. J Allergy Clin Immunol 2004; 114: 302-309.
18. Hamasur B, Kallenius G, Svenson SB. A new rapid and simple method for large-scale purification of mycobacterial lipoarabinomannan. FEMS Immunol Med Microbiol 1999; 24: 11-17.
19. Dubois M, Gilles K, Hamilton JK, Rebers PA, Smith F. A colorimetric method for the determination of sugars. Nature 1951; 168: 167.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
21. Deringer JR, Ely RJ, Monday SR, Stauffacher CV, Bohach GA. Vbeta-dependent stimulation of bovine and human T cells by host-specific staphylococcal enterotoxins. Infect Immun 1997; 65: 4048-4054.
22. SENASA Argentina. Programa nacional de control y erradicación de la tuberculosis bovina. http://www.senasa.gov.ar/contenido.php?to=n&iN=858&io=15899.
23. Mundo SL, Fontanals AM, Garcia M, Durrieu M, Alvarez E, Gentilini ER, et al. Bovine IgG1 antibodies against Mycobacterium avium subsp. paratuberculosis protein p34-cx improve association of bacteria and macrophages. Vet Res 2008; 39: 6.
24. Koets AP, Rutten VP, de Boer M, Bakker D, Valentin-Weigand P, van Eden W. Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection. Infect Immun 2001; 69: 1492-1498.
25. Watanabe Y, Watari E, Matsunaga I, Hiromatsu K, Dascher CC, Kawashima T, et al. BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components. Vaccine 2006; 24: 5700-5707.
26. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
27. Ito T, Hasegawa A, Hosokawa H, Yamashita M, Motohashi S, Naka T, et al. Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172. Int Immunol 2008; 20: 849-860.
28. Guenin-Mace L, Simeone R, Demangel C. Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression. Transbound Emerg Dis 2009; 56: 255-268.
29. Robiolo B, La Torre J, Maradei E, Beascoechea CP, Perez A, Seki C, et al. Confidence in indirect assessment of foot-and- mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 2010; 28: 6235-6241.
30. Roman F, Vaman T, Gerlach B, Markendorf A, Gillard P, Devaster JM. Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observerblind, randomised trial. Vaccine 2010; 28: 1740-1745.
31. Habjanec L, Halassy B, Tomasic J. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse. Int Immunopharmacol 2010; 10: 751-759.
32. Sun HX, Ye YP, Pan HJ, Pan YJ. Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice. Vaccine 2004; 22: 3882-3889.
33. Vordermeier HM, Dean GS, Rosenkrands I, Agger EM, Andersen P, Kaveh DA, et al. Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model. Clin Vaccine Immunol 2009; 16: 1443-1448.
34. Rosenkrands I, Agger EM, Olsen AW, Korsholm KS, Andersen CS, Jensen KT, et al. Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system. Infect Immun 2005; 73: 5817-5826.
35. Waters WR, Rahner TE, Palmer MV, Cheng D, Nonnecke BJ, Whipple DL. Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells. Infect Immun 2003; 71: 317-326.
36. Seo KS, Lee SU, Park YH, Davis WC, Fox LK, Bohach GA. Long-term staphylococcal enterotoxin C1 exposure induces soluble factor-mediated immunosuppression by bovine CD4+ and CD8+ T cells. Infect Immun 2007; 75: 260-269.
37. Berghaus LJ, Corbeil LB, Berghaus RD, Kalina WV, Kimball RA, Gershwin LJ. Effects of dual vaccination for bovine respiratory syncytial virus and Haemophilus somnus on immune responses. Vaccine 2006; 24: 6018-6027.
38. Estes DM, Brown WC. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet Immunol Immunopathol 2002; 90: 1-10.
39. Rothel JS, Corner LA, Lightowlers MW, Seow HF, McWaters P, Entrican G, et al. Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants. Vet Immunol Immunopathol 1998; 63: 167-183.
40. Waters WR, Palmer MV, Thacker TC, Payeur JB, Harris NB, Minion FC, et al. Immune responses to defined antigens of Mycobacterium bovis in cattle experimentally infected with Mycobacterium kansasii. Clin Vaccine Immunol 2006; 13: 611-619.